Potentiation of NGF-induced neurite outgrowth in PC12 cells by papaverine: Role played by PLC-γ, IP 3 receptors

Brain Research

Volumn 1377, Issue , 2011, Pages 32-40

  Itoh, Kanako ^a   Ishima, Tamaki ^a   Kehler, Jan ^b   Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b H LUNDBECK A S   (Denmark)

Author keywords

IP 3 receptors; Neurite outgrowth; Papaverine; PC12 cells; PDE10A; PLC

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [4 [1 METHYL 4 (4 PYRIDINYL) 3 PYRAZOLYL]PHENOXYMETHYL]QUINOLINE; 2 AMINOETHOXYDIPHENYLBORANE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PAPAVERINE; PHOSPHOLIPASE C GAMMA; RAF PROTEIN; RAS PROTEIN; XESTOSPONGIN C;

ARTICLE; CELL STRAIN; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL DIFFERENTIATION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; NERVE GROWTH FACTOR; NEURITES; NEUROGENESIS; PAPAVERINE; PC12 CELLS; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C GAMMA; RATS;

EID: 79951553138     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.12.075     Document Type: Article

References (43)

1. M.J. Berridge Inositol triphosphate and calcium signalling Nature 361 1993 315 325
2. V. Boswell-Smith, D. Spina, and C.P. Page Phosphodiesterase inhibitors Br. J. Pharmacol. 147 2006 S252 257
3. M.V. Chao Neurotrophins and their receptors: a convergence point for many signaling pathways Nat. Rev. Neurosci. 4 2003 299 309 (Pubitemid 37271375)
4. T. Chappie, J. Humphrey, F. Menniti, and C. Schmidt PDE10A inhibitors: an assessment of the current CNS drug discovery landscape Curr. Opin. Drug Discov. Devl. 12 2009 458 467
5. T.M. Coskran, D. Morton, F.S. Menniti, W.O. Adamowicz, R.J. Kleiman, A.M. Ryan, C.A. Strick, C.J. Schmidt, and D.T. Stephenson Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species J. Histochem. Cytochem. 54 2006 1205 1213 (Pubitemid 44623341)
6. J. Gafni, J.A. Munsch, T.H. Lam, M.C. Catlin, L.G. Costa, T.F. Molinski, and I.N. Pessah Xestospongins: potent membrane permeable blockers of the inositol 1, 4, 5-trisphosphate receptor Neuron 19 1997 723 733 (Pubitemid 27430757)
7. G. Gardos, and J.O. Cole Letter: Papaverine for tardive dyskinesia? N. Eng. J. Med. 292 1975 1355
8. G. Gardos, J.O. Cole, and C. Sniffin An evaluation of papaverine in tardive dyskinesia J. Clin. Pharmacol. 16 1976 304 310
9. G. Gardos, R.P. Granacher, J.O. Cole, and C. Sniffin The effects of papaverine in tardive dyskinesia Prog. Neuropsychopharmacol. 3 1979 543 550 (Pubitemid 10139945)
10. T.M. Gomez, and J.Q. Zheng The molecular basis for calcium-dependent axon pathfinding Nat. Rev. Neurosci. 7 2006 115 125 (Pubitemid 43151598)
11. S.M. Grauer, V.L. Pulito, R.L. Navarra, M.P. Kelly, C. Kelley, R. Graf, B. Langen, S. Logue, J. Brennan, L. Jiang, E. Charych, U. Egerland, F. Liu, K.L. Marquis, M. Malamas, T. Hage, T.A. Comery, and N.J. Brandon Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia J. Pharmacol. Exp. Ther. 331 2009 574 590
12. L.A. Greene, and A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl Acad. Sci. USA 73 1976 2424 2428
13. T.B. Halene, and S.J. Siegel PDE inhibitors in psychiatry-future options for dementia, depression and schizophrenia? Drug Discov Today 12 2007 870 878 (Pubitemid 47539966)
14. K. Hashimoto, and T. Ishima A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation factor eIF4AI PLoS ONE 5 2010 e15430
15. 2+ signals Trends Cell Biol. 14 2004 320 330 (Pubitemid 38798181)
16. E.J. Huang, and L.F. Reichardt Trk receptors: roles in neuronal signal transduction Annu. Rev. Biochem. 72 2003 609 642 (Pubitemid 36930455)
17. M. Iketani, C. Imaizumi, F. Nakamura, A. Jeromin, K. Mikoshiba, Y. Goshima, and K. Takei Regulation of neurite outgrowth mediated by neuronal calcium sensor-1 and inositol 1, 4, 5-trisphosphate receptor in nerve growth cones Neuroscience 161 2009 743 752
18. 3 receptors Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1656 1659
19. J. Kehler, and J.P. Kilburn Patented PDE10A inhibitors: novel compounds since 2007 Expert Opin. Ther. Pat. 19 2009 1715 1725
20. R.S. Kirby Impotence: diagnosis and management of male erectile dysfunction BMJ 308 1994 957 961 (Pubitemid 24111918)
21. J. Kotera, T. Sasaki, T. Kobayashi, K. Fujishige, Y. Yamashita, and K. Omori Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation J. Biol. Chem. 279 2004 4366 4375 (Pubitemid 38199025)
22. J.K. Liu, and W. Couldwell Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurismal subarachnoid hemorrhage Neurocrit. Care 2 2005 124 132 (Pubitemid 41270855)
23. -ΔΔCT Method Methods 25 2001 402 408 (Pubitemid 34164012)
24. 2+ channels Science 287 2000 1647 1651 (Pubitemid 30127765)
25. R.T. Malison, L.H. Price, E.J. Nestler, G.R. Heninger, and R.S. Duman Efficacy of papaverine addition for treatment - refractory major depression Am. J. Psychiatry 154 1997 579 580 (Pubitemid 27147620)
26. 2+ release J. Biochem. 122 1997 498 505 (Pubitemid 27443223)
27. 3 receptors Eur. J. Pharmacol. 648 2010 67 73
28. C.L. Newton, G.A. Mignery, and T.C. Sudhof Co-expression in vertebrate tissues and cell lines of multiple inositol 1, 4, 5-tiphosphate (InsP3) receptors with distinct affinities for InsP3 J. Biol. Chem. 269 1994 28613 28619 (Pubitemid 24366693)
29. 3 receptors and cellular signaling pathways PLoS ONE 3 2008 e2558
30. S. Patel, S.K. Joseph, and A.P. Thomas Molecular properties of inositol 1, 4, 5-triphosphate receptors Cell Calcium 25 1999 247 264 (Pubitemid 29251132)
31. R.D. Price, T. Yamaji, and N. Matsuoka FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway Br. J. Pharmacol. 140 2003 825 829 (Pubitemid 37464063)
32. R.D. Price, T. Yamaji, H. Yamamoto, Y. Higashi, K. Hanaoka, S. Yamazaki, M. Ishiye, I. Aramori, N. Matsuoka, S. Mutoh, T. Yanagihara, and B.G. Gold FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action Eur. J. Pharmacol. 509 2005 11 19 (Pubitemid 40248780)
33. H.A. Ring, and J. Serra-Mestres Neuropsychiatry of the basal ganglia J. Neurol. Neurosurg. Psychiatry 72 2002 12 21 (Pubitemid 34073089)
34. R.E. Rydel, and L.A. Greene Acidic and basic fibroblast growth factors promote stable neurite outgrowth and neuronal differentiation in cultures of PC12 cells J. Neurosci. 7 1987 3639 3653 (Pubitemid 18000691)
35. C.J. Schmidt, D.S. Chapin, J. Cianfrogna, M.L. Corman, M. Hajos, J.F. Harms, W.E. Hoffman, L.A. Lebel, S.A. McCarthy, F.R. Nelson, C. Proulx-LaFrance, M.J. Majchrzak, A.D. Ramirez, K. Schmidt, P.A. Seymour, J.A. Siuciak, F.D. Tingley 3rd, R.D. Williams, P.R. Verhoest, and F.S. Menniti Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia J. Pharmacol. Exp. Ther. 325 2008 681 690 (Pubitemid 351574819)
36. T.E. Seeger, B. Bartlett, T.M. Coskran, J.S. Culp, L.C. James, D.L. Krull, J. Lanfear, A.M. Ryan, C.J. Schmidt, C.A. Strick, A.H. Varghese, R.D. Williams, P.G. Wylie, and F.S. Menniti Immunohistochemical localization of PDE10A in the rat brain Brain Res. 985 2003 113 126 (Pubitemid 37088176)
37. E.H. Simpson, C. Kellendonk, and E. Kandel A possible role of the striatum in the pathogenesis of cognitive symptoms of schizophrenia Neuron 65 2010 585 596
38. J.A. Siuciak, D.S. Chapin, J.F. Harms, L.A. Lebel, S.A. McCarthy, L. Chambers, A. Shrikhande, S. Wong, F.S. Menniti, and C.J. Schmidt Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis Neuropharmacology 51 2006 386 396 (Pubitemid 44061894)
39. J.A. Siuciak, and C.A. Strick Treating neuropsychiatric disorders with PDE10A inhibitors Drug Discov. Today Ther. Strateg. 3 2006 527 532 (Pubitemid 46076168)
40. S. Sivalingam, A. Levine, and J. Dunning What is the optimal vasodilator for preventing spasm in the left internal mammary artery during coronary arterial bypass grafting? Interact. Cardiovasc. Thorac. Surg. 4 2005 365 371 (Pubitemid 41283759)
41. M.V. Sofroniew, C.L. Howe, and W.C. Mobley Nerve growth factor signaling, neuroprotection, and neural repair Annu. Rev. Neurosci. 24 2001 1217 1281 (Pubitemid 32695259)
42. P.R. Verhoest, D.S. Chapin, M. Corman, K. Fonseca, J.F. Harms, X. Hou, E.S. Marr, F.S. Menniti, F. Nelson, R. O'Connor, J. Pandit, C. Proulx-Lafrance, A.W. Schmidt, C.J. Schmidt, J.A. Suiciak, and S. Liras Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]- quinolone (PF-2545920) for treatment of schizophrenia J. Med. Chem. 52 2009 5188 5196
43. F. Yencilek, C. Aktas, C. Goktas, C. Yilmaz, U. Yilmaz, and K. Sarica Role of papaverine hydrochloride administration in patients with intractable renal colic: randomized prospective trial Urology 72 2008 987 990